7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline(CAS: 60771-18-8)

The compound 7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline (CAS: 60771-18-8) is subject to various regulatory guidelines. It may be classified and labeled according to the Globally Harmonized System (GHS) for hazardous chemicals. In the European Union, it falls under the REACH regulations for the Registration, Evaluation, Authorisation, and Restriction of Chemicals. Additionally, the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) may have specific requirements regarding its use, testing, and disposal.

There are alternative reagents and methods that can be used in the synthesis of 7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline (CAS: 60771-18-8). For instance, 2,4-dichloro-6-methoxyquinazoline can be modified with different functional groups or alternative substituents. Additionally, other quinazoline derivatives with similar structures can serve as alternatives, depending on the specific application and desired properties.

The market for 7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline (CAS: 60771-18-8) is primarily driven by its use in pharmaceuticals and research. Recent trends indicate a growing interest in its application as an intermediate for drug synthesis and as a component in anti-inflammatory and anti-cancer treatments. Emerging research focuses on optimizing its synthesis and exploring its potential in novel therapeutic areas.

Waste containing 7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline (CAS: 60771-18-8) should be handled according to strict environmental regulations. It is recommended to collect the waste in appropriate containers and ensure proper labeling. The waste should then be disposed of through incineration or professional waste disposal services that comply with local and international environmental standards. Protective measures such as gloves and safety goggles should be worn during handling to prevent exposure and ensure safety.